Study supports tobacco link to ovarian cancer

September 12, 2012
A major outcome was evidence to support smoking’s link to the disease, which until recently had not been considered a risk factor. Image: Micke Jakobsson

(Medical Xpress)—Researchers from Curtin University's School of Public Health have contributed to a comprehensive international study examining risk factors for ovarian cancer.

Prof Andy Lee and Prof Colin Binns took part as members of the Collaborative Group on of based at Oxford University and funded by UK .

Their work involved the completion of two studies in China, which were fed into a pool of data totalling 28,114 women with, and 94,942 women without, ovarian cancer.

The aim of the project was to gather and analyse from published and unpublished sources which could shed light on the second most commonly diagnosed gynaecological cancer in Australia, one which Cancer Australia lists as having a five-year survival rate of only 40 per cent.

A major outcome was evidence to support smoking's link to the disease, which until recently had not been considered a risk factor.

"Previously there was only a weak link between smoking and ovarian cancer, coming from a paper in 2009. This new analysis firmly establishes that relationship for one particular type of ovarian cancer, mucinoid tumours, which account for about 15 per cent of the total of all ovarian cancers," Prof Binns says.

Interestingly, increased smoking-related occurrences of mucinoid tumours showed up primarily in borderline malignant tumours with no significant association with those fully malignant. Occurrences of other types of ovarian cancers showed no significant differences between current smokers and those how had never lit up.

Outcomes were consistent along 13 socio-demographic and which were taken into account, including body-mass index, use of alcohol, use of and menopausal hormone therapy.

Prof Binns says more research was needed to understand how smoking stimulated the creation of mucinoid tumours, but stressed the first step in prevention was for women to quit cigarettes.

"While giving up smoking is the best advice, we did find evidence that drinking green tea, breastfeeding, eating fruit and vegetables, getting regular exercise and avoiding obesity were also beneficial," he says.

Prof Binns says the study was a step forward and reflected well the quality of work being done at Curtin University.

"We are very proud that the work of the School of Public Health is world class and can be included in this collaborative effort with other top universities from around the world," he says.

Explore further: Ovarian stimulation for IVF treatment increases risk of borderline ovarian tumors later in life

More information: 'Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies' appears in The Lancet Oncology volume 13, issue 9.

Related Stories

Ovarian stimulation for IVF treatment increases risk of borderline ovarian tumors later in life

October 27, 2011
Researchers from The Netherlands have found that subfertile women whose ovaries are stimulated into producing extra eggs for in vitro fertilisation (IVF) have an increased risk of ovarian malignancies, in particular borderline ...

Study links endometriosis with increased risk of developing 3 specific types of ovarian cancer

February 21, 2012
Women with a history of endometriosis are significantly more likely to develop three specific types of ovarian cancer (clear cell, endometrioid, and low-grade serous), according to an article published Online First in the ...

Pill and pregnancy have biggest effects on ovarian cancer risk

October 26, 2011
(Medical Xpress) -- Taking the Pill for 10 years can reduce the risk of ovarian cancer by almost half (45 per cent), new research part-funded by Cancer Research UK shows today.

Recommended for you

Drug suppresses spread of breast cancer caused by stem-like cells

December 12, 2017
Rare stem-like tumor cells play a critical role in the spread of breast cancer, but a vulnerability in the pathway that powers them offers a strategy to target these cells using existing drugs before metastatic disease occurs, ...

MRI scans predict patients' ability to fight the spread of cancer

December 12, 2017
A simple, non-invasive procedure that can indicate how long patients with cancer that has spread to the brain might survive and whether they are likely to respond to immunotherapy has been developed by researchers in Liverpool.

A new weapon against bone metastasis? Team develops antibody to fight cancer

December 11, 2017
In the ongoing battle between cancer and modern medicine, some therapeutic agents, while effective, can bring undesirable or even dangerous side effects. "Chemo saves lives and improves survival, but it could work much better ...

Insights on how SHARPIN promotes cancer progression

December 11, 2017
Researchers at Sanford Burnham Prebys Medical Discovery (SBP) and the Technion in Israel have found a new role for the SHARPIN protein. In addition to being one of three proteins in the linear ubiquitin chain assembly complex ...

Glioblastoma survival mechanism reveals new therapeutic target

December 11, 2017
A Northwestern Medicine study, published in the journal Cancer Cell, has provided new insights into a mechanism of tumor survival in glioblastoma and demonstrated that inhibiting the process could enhance the effects of radiation ...

Liver cancer: Lipid synthesis promotes tumor formation

December 11, 2017
Lipids comprise an optimal energy source and an important cell component. Researchers from the Biozentrum of the University of Basel and from the University of Geneva have now discovered that the protein mTOR stimulates the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.